Bitget App
Trade smarter
MarketsTradeFuturesStocksEarnInstitutionAI & More
JPMorgan raises Regeneron Pharmaceuticals (REGN.US) target price to $950

JPMorgan raises Regeneron Pharmaceuticals (REGN.US) target price to $950

智通财经智通财经2026/10/06 04:41
Show original

JPMorgan has raised the price target for Regeneron Pharmaceuticals (REGN.US) from $900 to $950.

JPMorgan: Raises Regeneron Pharmaceuticals (REGN.US) target price from $900 to $950.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.